Cyberonics on course to financial recovery
This article was originally published in Clinica
Cyberonics' efforts to kick its finances back into shape look to be paying off as the neuromodulation technology specialist succeeded in achieving its first operating profit in over three years, as well as positive operating cash flow.
You may also be interested in...
A surge in Chinese applications for clinical trials for coronavirus treatments, and a fall in patient numbers, are complicating recruitment efforts for the most promising drugs, prompting official moves to tighten study rules.